• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南非夸祖鲁 - 纳塔尔省黑人中卡波西肉瘤发病率上升(1983 - 2006年)

Increasing incidence of Kaposi's sarcoma in black South Africans in KwaZulu-Natal, South Africa (1983-2006).

作者信息

Mosam A, Carrara H, Shaik F, Uldrick T, Berkman A, Aboobaker J, Coovadia H M

机构信息

Department of Dermatology, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal.

出版信息

Int J STD AIDS. 2009 Aug;20(8):553-6. doi: 10.1258/ijsa.2008.008372.

DOI:10.1258/ijsa.2008.008372
PMID:19625587
Abstract

The aim of the study was to describe the temporal trends in the incidence of Kaposi's sarcoma (KS) in black South Africans in KwaZulu-Natal (KZN). The study was designed as a retrospective record review. The incidence of Kaposi's sarcoma was estimated using administrative records for patients receiving care for KS through public sector oncology clinics in KZN, 1983-2006. Annual age-standardized incidence rates were calculated using provincial census data for the denominator. Age-specific rates were calculated for the pre-AIDS (1983-1989) and for the generalized AIDS epidemic eras (2006). Age-standardized incidence of KS increased in KZN from <1:100,000 in 1990 to at least 15:100,000 in 2006; this increase was observed in both men and women. There was a shift in the peak age-specific incidence rates from the sixth decade of life in the pre-AIDS era to the fourth and fifth decades in the AIDS era. In conclusion, KS is a growing public health problem in KZN, South Africa. These data reinforce the need for comprehensive national access to and roll-out of antiretroviral drugs, given their success in prevention and treatment of KS in first-world settings.

摘要

该研究的目的是描述夸祖鲁 - 纳塔尔省(KZN)南非黑人中卡波西肉瘤(KS)发病率的时间趋势。该研究设计为回顾性记录审查。利用1983 - 2006年通过KZN公共部门肿瘤诊所接受KS治疗的患者的管理记录来估计卡波西肉瘤的发病率。使用省级人口普查数据作为分母计算年度年龄标准化发病率。计算了艾滋病流行前(1983 - 1989年)和广泛艾滋病流行时代(2006年)的年龄别发病率。KZN中KS的年龄标准化发病率从1990年的<1:100,000增加到2006年至少15:100,000;男性和女性均出现这种增加。年龄别发病率的峰值从艾滋病流行前时代的第六个十年转移到了艾滋病时代的第四和第五个十年。总之,KS在南非KZN是一个日益严重的公共卫生问题。鉴于抗逆转录病毒药物在第一世界环境中预防和治疗KS方面取得的成功,这些数据强化了全面普及和推广抗逆转录病毒药物的必要性。

相似文献

1
Increasing incidence of Kaposi's sarcoma in black South Africans in KwaZulu-Natal, South Africa (1983-2006).南非夸祖鲁 - 纳塔尔省黑人中卡波西肉瘤发病率上升(1983 - 2006年)
Int J STD AIDS. 2009 Aug;20(8):553-6. doi: 10.1258/ijsa.2008.008372.
2
Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.南非艾滋病毒感染患者的卡波西肉瘤:抗逆转录病毒治疗时代的多队列研究。
Int J Cancer. 2014 Dec 1;135(11):2644-52. doi: 10.1002/ijc.28894. Epub 2014 May 2.
3
Variants of Kaposi's sarcoma in Southern Africa. A retrospective analysis (1980-1992).南非卡波西肉瘤的变体。一项回顾性分析(1980 - 1992年)
Acta Oncol. 1996;35(2):193-9. doi: 10.3109/02841869609098501.
4
Epidemiology of Kaposi's sarcoma in sub-Saharan Africa.撒哈拉以南非洲地区卡波西肉瘤的流行病学。
Cancer Epidemiol. 2022 Jun;78:102167. doi: 10.1016/j.canep.2022.102167. Epub 2022 Apr 30.
5
An evaluation of the early effects of a combination antiretroviral therapy programme on the management of AIDS-associated Kaposi's sarcoma in KwaZulu-Natal, South Africa.南非夸祖鲁 - 纳塔尔省抗逆转录病毒联合治疗方案对艾滋病相关卡波西肉瘤治疗早期效果的评估。
Int J STD AIDS. 2011 Nov;22(11):671-3. doi: 10.1258/ijsa.2009.009145.
6
Characteristics of HIV-1-associated Kaposi's sarcoma among women and men in South Africa.南非男女中与HIV-1相关的卡波西肉瘤的特征。
Int J STD AIDS. 2008 Jun;19(6):400-5. doi: 10.1258/ijsa.2008.007301.
7
Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma.经典型、非洲地方性及艾滋病相关流行性卡波西肉瘤的临床表现。
J Am Acad Dermatol. 1990 Jun;22(6 Pt 2):1237-50. doi: 10.1016/0190-9622(90)70169-i.
8
Epidemic AIDS-related Kaposi's sarcoma in southern Africa: experience at the Johannesburg General Hospital (1980-1990).非洲南部与艾滋病相关的流行性卡波西肉瘤:约翰内斯堡综合医院的经验(1980 - 1990年)
Trans R Soc Trop Med Hyg. 1994 Jul-Aug;88(4):434-6. doi: 10.1016/0035-9203(94)90419-7.
9
Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.非洲南部艾滋病相关及地方性卡波西肉瘤的化疗
Int J Dermatol. 1995 Oct;34(10):729-32. doi: 10.1111/j.1365-4362.1995.tb04665.x.
10
Kaposi's sarcoma in South Africa.南非的卡波西肉瘤。
J Natl Cancer Inst Monogr. 2001(28):1-4. doi: 10.1093/oxfordjournals.jncimonographs.a024250.

引用本文的文献

1
Skin Cancer in People of Color: A Systematic Review.《有色人种的皮肤癌:系统评价》。
Am J Clin Dermatol. 2022 Mar;23(2):137-151. doi: 10.1007/s40257-021-00662-z. Epub 2021 Dec 13.
2
'RNA circles of influence' in Kaposi sarcoma.卡波西肉瘤中的“RNA影响圈”
Ann Transl Med. 2019 Jul;7(Suppl 3):S109. doi: 10.21037/atm.2019.05.17.
3
Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA.卡波氏肉瘤相关疱疹病毒编码的环状 RNA 的发现和一种人类抗病毒环状 RNA。
Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):12805-12810. doi: 10.1073/pnas.1816183115. Epub 2018 Nov 19.
4
Health-Related Quality of Life in Patients Treated With Antiretroviral Therapy Only Versus Chemotherapy and Antiretroviral Therapy for HIV-Associated Kaposi Sarcoma: A Randomized Control Trial.仅接受抗逆转录病毒疗法与接受化疗及抗逆转录病毒疗法治疗HIV相关卡波西肉瘤患者的健康相关生活质量:一项随机对照试验
J Glob Oncol. 2018 Oct;4:1-9. doi: 10.1200/JGO.18.00105.
5
Randomized Phase IIA Trial of Gemcitabine Compared With Bleomycin Plus Vincristine for Treatment of Kaposi's Sarcoma in Patients on Combination Antiretroviral Therapy in Western Kenya.在肯尼亚西部接受联合抗逆转录病毒治疗的患者中,吉西他滨与博来霉素加长春新碱治疗卡波西肉瘤的随机IIA期试验。
J Glob Oncol. 2018 Sep;4:1-9. doi: 10.1200/JGO.17.00077.
6
A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi Sarcoma.索拉非尼(BAY 43 - 9006)用于卡波西肉瘤患者的Ib期研究。
Oncologist. 2017 May;22(5):505-e49. doi: 10.1634/theoncologist.2016-0486. Epub 2017 Mar 24.
7
Challenges in the detection, prevention, and treatment of HIV-associated malignancies in low- and middle-income countries in Africa.在非洲中低收入国家,艾滋病毒相关恶性肿瘤的检测、预防和治疗面临的挑战。
J Acquir Immune Defic Syndr. 2014 Sep 1;67 Suppl 1(0 1):S17-26. doi: 10.1097/QAI.0000000000000255.
8
Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South Africa.口腔人类免疫缺陷病毒相关卡波西肉瘤:南非加兰夸地区的一项临床研究
AIDS Res Treat. 2012;2012:873171. doi: 10.1155/2012/873171. Epub 2012 Sep 12.
9
Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression.卡波西肉瘤相关疱疹病毒 microRNAs 靶向 IRAK1 和 MYD88,这两种蛋白都是 Toll 样受体/白介素-1R 信号转导通路的组成部分,以降低炎症细胞因子的表达。
J Virol. 2012 Nov;86(21):11663-74. doi: 10.1128/JVI.01147-12. Epub 2012 Aug 15.
10
Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.贝伐珠单抗治疗接受抗逆转录病毒治疗的 HIV 相关卡波西肉瘤患者的 II 期研究。
J Clin Oncol. 2012 May 1;30(13):1476-83. doi: 10.1200/JCO.2011.39.6853. Epub 2012 Mar 19.